Immune checkpoint inhibitors and corneal transplant rejection: a call for awareness

Harpal Singh Sandhu; Houman D Hemmati; Reza Dana

doi:10.2217/imt-2020-0100

Immune checkpoint inhibitors and corneal transplant rejection: a call for awareness

Immunotherapy. 2020 Sep;12(13):947-949. doi: 10.2217/imt-2020-0100. Epub 2020 Aug 25.

Authors

Harpal Singh Sandhu¹, Houman D Hemmati², Reza Dana³

Affiliations

¹ Department of Ophthalmology & Visual Sciences, University of Louisville, Louisville, KY 40202, USA.
² Department of Ophthalmology, Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.
³ Department of Ophthalmology, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, MA 02114, USA.

No abstract available

Keywords: autoimmunity; cancer immunology; cellular immunology; checkpoint inhibitors; clinical immunology; immunity-adaptive; immunoprivilege; immunotherapy; molecular immunology; transplantation.

Publication types

Editorial
Review

MeSH terms

Corneal Transplantation*
Graft Rejection / chemically induced*
Humans
Immune Checkpoint Inhibitors / adverse effects*
Immunotherapy / adverse effects*

Substances

Immune Checkpoint Inhibitors